RLS
RLS Global AB (publ)
Save
35.62M
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Drug Manufacturers - Specialty & Generic
Industry
RLS Global AB (publ), a medical technology company, develops and sells products for the treatment of illnesses in wound and oral care in Sweden. Its products include ChloraSolv that is used for the treatment of chronic diabetic foot and leg ulcers for diabetic patients; and CariSolv, a gel used for removing caries. The company was founded in 1996 and is based in Mölndal, Sweden.
Similar securities
Based on sector and market capitalization
Report issue